LUXZYLA

Serial Number 90674894
606

Registration Progress

Application Filed
Apr 27, 2021
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Trademark Image

LUXZYLA

Basic Information

Serial Number
90674894
Filing Date
April 27, 2021
Published for Opposition
October 24, 2023
Abandonment Date
July 22, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 22, 2024
Classes
005

Rights Holder

Cycle Pharmaceuticals Ltd.

99
Address
The Broers Building
21 JJ Thomson Ave
Cambridge CB30FA
GB

Ownership History

Cycle Pharmaceuticals Ltd.

Original Applicant
99
Cambridge GB

Cycle Pharmaceuticals Ltd.

Owner at Publication
99
Cambridge GB

Legal Representation

Attorney
Mary Frances Love

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Jul 22, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 22, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 19, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 21, 2023 ALIE A ASSIGNED TO LIE Loading...
Apr 7, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 7, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 7, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 7, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 11, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 30, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 30, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 17, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 5, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 5, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 5, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 3, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 30, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical agents for the treatment of Wilson's Disease; pharmaceutical agents for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of Wilson's Disease; pharmaceutical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of Wilson's Disease; pharmaceuticals for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary pharmaceutical preparations for treatment of disorders of the metabolism and digestive system; veterinary pharmaceutical preparations, namely, antioxidants; Veterinary pharmaceutical preparations, namely, pain relief medications; Veterinary pharmaceutical preparations for treatment of chronic illnesses; Veterinary pharmaceutical preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system; Dietary supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Dietary supplements for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system; biological preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; biological preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of disorders of the metabolism and digestive system; chemical preparations for medical purposes, namely, for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of disorders of the metabolism and digestive system; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of lysosomal storage disorders and lysosomal storage diseases; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of Wilson's Disease; Pharmaceutical preparations in the form of drugs and medicines for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form drugs and medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form drugs and medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for medical purposes for the treatment of disorders of the metabolism and digestive system; enzyme preparations for medical purposes the treatment of lysosomal storage disorders and lysosomal storage diseases; enzyme preparations for medical purposes the treatment of Wilson's Disease; medical enzyme preparations for medical purposes in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems; medical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches

Additional Information

Translation
The wording "LUXZYLA" has no meaning in a foreign language.

Classification

International Classes
005